Categories: Business

Sudeep Pharma IPO Debut Today, Raises ₹895 Crore Amid Massive Oversubscription – What Investors Need to Know

Sudeep Pharma debuts on BSE and NSE today after a highly oversubscribed IPO raising ₹895 crore. Shares will list under ‘B’ group and begin trading from 10:00 AM.

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by Aishwarya Samant
Last updated: November 28, 2025 09:59:51 IST

Sudeep Pharma IPO: all set to become a publicly traded company today via BSE and NSE.

Today, November 28, marks the day for Sudeep Pharma to get listed on the Indian stock market. The company was able to raise a substantial amount from its initial public offering (IPO), making the stock market debut a promising one. The IPO, which was open for subscriptions from November 21 to 25, attracted significant interest from all investor types, resulting in high oversubscription numbers. Prospective investors were then informed about the allotments on November 26, paving the way for the company’s listing on both stock exchanges, BSE and NSE. Investors in the pharma sector and specialty ingredients companies are likely to closely monitor Sudeep Pharma’s debut due to the hype created in the market.

Sudeep Pharma IPO: Key Details

Category Details
Total IPO Raised ₹895 crore
Fresh Issue 16.02 lakh shares worth ₹95 crore
Offer for Sale (OFS) 1.35 crore shares worth ₹800 crore
IPO Price Band ₹563–₹593 per share
Total Subscription 93.72×
Retail Investors (RII) 15.65×
Non-Institutional Investors (NII) 116.72×
Qualified Institutional Buyers (QIB) 213.08×
Book-Running Lead Manager ICICI Securities
IPO Registrar MUFG Intime India

Sudeep Pharma IPO GMP

Listing Details

According to a BSE notice, Sudeep Pharma’s equity shares will list under the ‘B’ Group of Securities starting Friday, November 28, 2025.
The stock will take part in the Special Pre-Open Session (SPOS) and begin trading from 10:00 AM.

BSE Confirms Listing From Today

A BSE notice stated:
“Trading Members of the Exchange are hereby informed that effective from Friday, November 28, 2025, the equity shares of Sudeep Pharma Limited shall be listed and admitted to dealings on the Exchange in the list of ‘B’ Group of Securities.”

Recent Posts

How Rupeezy Is Helping Indian Investors Navigate Today’s Complex Market Landscape

Successful investing today depends on disciplined decision-making, reliable information, and technology-driven platforms like Rupeezy that…

January 20, 2026

Streaming Wars Escalate As Netflix Makes $82.7 Billion All-Cash Bid For Warner Bros, Shuts Out Paramount

Netflix has submitted an all-cash $82.7 billion bid for Warner Bros Discovery’s studio and streaming…

January 20, 2026

Strategy To Boost UK education Abroad In Major £40Bn Growth Drive

The UK has launched a new International Education Strategy to grow education exports to £40…

January 20, 2026